When we measured ALT and AST in plasma of triagonist treated male and female mice, we detected a significant reduction in ALT levels in female mice and a clear trend of reduced ALT levels in male mice.
← all excerpts
Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice.
1
—
—